Those pushing Medicare for All rely on the presumption that it will generate huge administrative efficiencies. But they greatly underestimate the program's real administrative cost.
Patients come in all sizes and shapes, and with varying tolerance for complications and risk. Is it plausible that a single dosing regimen can optimize treatment for everybody?
The reform of medical education is a usually boring conversation that needs its own reform. The discussion we have on this episode does just that.
We revisit the question of brain death, this time with a more practical focus. What should doctors tell families of patients who fulfill neurological criteria for brain death?
Economic knowledge should not be the sole province of technical experts, but it is. The price we pay for this ignorance is that most people can easily fall prey to the political class and to the technocrats whose economic theory is generally far from sound.
Should doctors have something to say about guns? If so, what should they say?
Brand recognition, competition, and de-regulation are the keys to a more affordable and more competitive drug market.
Bureaucratic appeal to measurement as a check on personal judgment rules the medical field but also permeates our entire culture. Guest Jerry Z. Muller brings a valuable historical perspective to the subject.
Healthcare under the Bernie Sanders plan would be so expansive, centralized, and monolithic as to make the Canadian system look sensible by comparison.
Could pushing policy levers on a grand scale conceivably have negative unintended consequences?
